Sleep Modulation to Treat Depression

Recruiting N/A Interventional Study
Major Depressive Disorder Healthy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 – 60
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
60 (estimated)
Sponsor
Christoph Nissen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Current first-line treatments for major depression (antidepressants and psychotherapy) show a long latency to response, and less than half of all patients experience full remission with optimized treatment, indicating the need for new developments. The aim of this study is to extend and further develop a longstanding line of research of using sleep neurophysiology as a 'window to the brain' and tr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Written informed consent * MDD according to ICD-10 criteria (F32.1/2, F33.1/2; i.e. unipolar depression) for patient group Exclusion Criteria: * Relevant psychiatric disorders (other than MDD for the patient group), such as organic psychiatric disorders, lifetime history of …
Contacts

Christoph Nissen, Prof. Dr. med.

+41.22.305.45.38

christoph.nissen@hug.ch

CONTACT